AIMS: To determine whether specific IgE and skin prick test correlate better in predicting reaction severity during a double-blinded placebo controlled food challenge (DBPCFC) for egg, milk, and multiple tree nut allergens. STUDY DESIGN: Prospective study. PLACE AND DURATION OF STUDY: Department of Pediatrics, Stanford University School of Medicine, August 2009 and ongoing. METHODOLOGY: We examined the reaction severity of twenty-four subjects to nine possible food allergens: milk, egg, almond, cashew, hazelnut, peanut, sesame, pecan and walnut. Specific IgE and SPT were performed before each DBPCFC. DBPCFC results were classified into mild (1), moderate (2), or severe (3) reactions using a modified Bock's criteria. RESULTS: Twenty four subjects underwent a total of 80 DBPCFC. Eighty percent of all DBPCFCs resulted in a positive reaction. A majority, 71%, were classified as mild. No reactions occurred with a SPT of zero mm while three reactions occurred with a negative specific IgE. All reactions were reversible with medication. CONCLUSION: These data suggest that SPT and specific IgE levels are not associated with reaction severity (p<0.64 and 0.27, respectively). We also found that combining specific IgE and SPT improved specificity but did not help to achieve clinically useful sensitivity. For instance, an SPT > 5mm had a sensitivity of 91% and specificity of 50%. Combining SPT > 5mm and IgE > 7 resulted in a reduced sensitivity of 64%. Unexpectedly, a history of anaphylaxis 70% (n=17) was not predictive of anaphylaxis on challenge 4% (n=2).
AIMS: To determine whether specific IgE and skin prick test correlate better in predicting reaction severity during a double-blinded placebo controlled food challenge (DBPCFC) for egg, milk, and multiple tree nut allergens. STUDY DESIGN: Prospective study. PLACE AND DURATION OF STUDY: Department of Pediatrics, Stanford University School of Medicine, August 2009 and ongoing. METHODOLOGY: We examined the reaction severity of twenty-four subjects to nine possible food allergens: milk, egg, almond, cashew, hazelnut, peanut, sesame, pecan and walnut. Specific IgE and SPT were performed before each DBPCFC. DBPCFC results were classified into mild (1), moderate (2), or severe (3) reactions using a modified Bock's criteria. RESULTS: Twenty four subjects underwent a total of 80 DBPCFC. Eighty percent of all DBPCFCs resulted in a positive reaction. A majority, 71%, were classified as mild. No reactions occurred with a SPT of zero mm while three reactions occurred with a negative specific IgE. All reactions were reversible with medication. CONCLUSION: These data suggest that SPT and specific IgE levels are not associated with reaction severity (p<0.64 and 0.27, respectively). We also found that combining specific IgE and SPT improved specificity but did not help to achieve clinically useful sensitivity. For instance, an SPT > 5mm had a sensitivity of 91% and specificity of 50%. Combining SPT > 5mm and IgE > 7 resulted in a reduced sensitivity of 64%. Unexpectedly, a history of anaphylaxis 70% (n=17) was not predictive of anaphylaxis on challenge 4% (n=2).
Authors: Marjolein Wensing; André H Penninks; Susan L Hefle; Stef J Koppelman; Carla A F M Bruijnzeel-Koomen; André C Knulst Journal: J Allergy Clin Immunol Date: 2002-12 Impact factor: 10.793
Authors: Anna Nowak-Wegrzyn; Amal H Assa'ad; Sami L Bahna; S Allan Bock; Scott H Sicherer; Suzanne S Teuber Journal: J Allergy Clin Immunol Date: 2009-06 Impact factor: 10.793
Authors: T Boyano Martínez; C García-Ara; J M Díaz-Pena; F M Muñoz; G García Sánchez; M M Esteban Journal: Clin Exp Allergy Date: 2001-09 Impact factor: 5.018
Authors: Brynn Kevin Wainstein; Anthony Yee; Donna Jelley; Mary Ziegler; John B Ziegler Journal: Pediatr Allergy Immunol Date: 2007-05 Impact factor: 6.377
Authors: Rhoda Kagan; Doug Hayami; Lawrence Joseph; Yvan St Pierre; Ann E Clarke Journal: Ann Allergy Asthma Immunol Date: 2003-06 Impact factor: 6.347
Authors: Lana Rosenfield; Michael William Tsoulis; Kirolos Milio; Meghan Schnittke; Harold Kim Journal: Allergy Asthma Clin Immunol Date: 2017-01-19 Impact factor: 3.406
Authors: Alexandra F Santos; George Du Toit; Colin O'Rourke; Natalia Becares; Natália Couto-Francisco; Suzana Radulovic; Ekaterina Khaleva; Monica Basting; Kristina M Harris; David Larson; Peter Sayre; Marshall Plaut; Graham Roberts; Henry T Bahnson; Gideon Lack Journal: J Allergy Clin Immunol Date: 2020-04-18 Impact factor: 10.793
Authors: Mareen R Datema; Sarah A Lyons; Montserrat Fernández-Rivas; Barbara Ballmer-Weber; André C Knulst; Riccardo Asero; Laura Barreales; Simona Belohlavkova; Frédéric de Blay; Michael Clausen; Ruta Dubakiene; Cristina Fernández-Perez; Philipp Fritsche; David Gislason; Karin Hoffmann-Sommergruber; Monika Jedrzejczak-Czechowicz; Laurian Jongejan; Marek L Kowalski; Tanya Z Kralimarkova; Jonas Lidholm; Nikolaos G Papadopoulos; Todor A Popov; Nayade Del Prado; Ashok Purohit; Isabel Reig; Suranjith L Seneviratne; Athanassios Sinaniotis; Emilia Vassilopoulou; Serge A Versteeg; Stefan Vieths; Paco M J Welsing; E N Clare Mills; Thuy-My Le; Aeilko H Zwinderman; Ronald van Ree Journal: Front Allergy Date: 2021-06-07